Table 3.
Parameters | n | hTRTmRNA positive (%) | P | hTRT protein positive(%) | P |
Gender | |||||
Male | 42 | 35 (83.3) | 0.309 | 39 (92.9) | 0.180 |
Female | 11 | 7(63.6) | 8 (72.7) | ||
Age(years) | |||||
<55 | 25 | 18 (72.0) | 0.219 | 20 (80.0) | 0.147 |
≥ 55 | 28 | 24 (85.7) | 27 (96.4) | ||
Tumor size(cm) | |||||
< 5 | 24 | 20 (83.3) | 0.735 | 22 (91.7) | 0.678 |
≥ 5 | 29 | 22 (75.9) | 25 (86.2) | ||
Tumor location | |||||
Cardia | 26 | 23 (88.5) | 0.128 | 24 (92.3) | 0.529 |
Body | 16 | 10 (62.5) | 13 (81.3) | ||
Antrum | 11 | 9 (81.8) | 10 (90.9) | ||
Lymph node metastasis | |||||
Absent | 25 | 18 (72.0) | 0.219 | 20 (80.0) | 0.089 |
Present | 28 | 24 (85.7) | 27 (96.4) | ||
Invasion depth | |||||
Not invading serosa | 8 | 7(87.5) | 0.879 | 7 (87.5) | 1.000 |
Invading serosa | 45 | 35 (77.8) | 40 (88.9) | ||
Clinical stage | |||||
I and II | 47 | 37 (78.7) | 1.000 | 41 (87.2) | 0.806 |
III and IV | 6 | 5 (83.3) | 6 (100.0) |